Os 182 melhores médicos do mundo para o tratamento de cancro do colo do útero

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

A Dra. Zalmanova especializa-se em radioterapia para o cancro do colo do útero no Assuta Medical Center.

• Radioterapeuta com foco em tratamentos para o cancro do colo do útero
• Trabalha no Assuta Medical Center, uma unidade de saúde de referência
• Dedicada a prestar cuidados personalizados a cada paciente

Especialista em oncoginecologia – O Dr. Viganò concentra-se no tratamento cirúrgico do cancro do colo do útero, incluindo procedimentos laparoscópicos minimamente invasivos.

• Experiência no tratamento de vários cancros ginecológicos
• Realiza cirurgias laparoscópicas avançadas para um tratamento preciso
• Trabalha no San Raffaele, uma instituição médica líder

Especialista em oncoginecologia no Samsung Medical Center – focando exclusivamente em casos de câncer do colo do útero.

• Experiência em tratamentos avançados para câncer do colo do útero
• Trabalha em um centro médico líder na Coreia do Sul
• Dedicado ao atendimento personalizado ao paciente

O médico é um radiologista altamente qualificado com uma vasta experiência clínica que abrange mais de duas décadas. Graduado pela Faculdade de Medicina da Universidade de Istambul, o médico completou uma formação especializada em radiologia e ocupou cargos em vários centros de imagem e instituições médicas de prestígio, incluindo o Neolife Medical Center. A experiência clínica do médico é apoiada por uma sólida formação em diagnóstico por imagem, com um foco particular em neurorradiologia e aplicações avançadas de ressonância magnética.

O médico é um membro ativo de várias organizações profissionais, incluindo a RSNA e a Sociedade Europeia de Radiologia. Ao longo de uma carreira distinta, o médico contribuiu significativamente para a literatura médica através de numerosas publicações revistas por pares e recebeu múltiplos prémios pela excelência em diagnóstico por imagem e apresentações de casos clínicos.

O Dr. Kim Tae Joong é um ginecologista e oncologista ginecológico dedicado no Samsung Medical Center.

• Especializado em oncologia ginecológica
• Trabalha num centro médico líder na Coreia do Sul
• Foca-se no tratamento do cancro do colo do útero

Investigadora principal em ensaios clínicos para o cancro do colo do útero – A Dra. Oaknin lidera a investigação sobre angiogénese e reparação de ADN no Hospital Quiron de Barcelona.

• Autora de mais de 100 publicações sobre tumores ginecológicos
• Representante espanhola no Comité de Cancro do Colo do Útero do GCIG
• Membro do corpo docente do Gyn-Track na ESMO
• Especialista em Oncologia Médica no Hospital Universitario de la Princesa

O Dr. Jaime Antonio Barros é cirurgião plástico e reconstrutivo em Bogotá. Realiza lifting facial de plano profundo e contorno corporal com tecnologia VASER. O Dr. Barros completou estágios clínicos no Hospital de la Santa Creu i Sant Pau, em Barcelona, e é membro da Sociedade Colombiana de Cirurgia Plástica (SCCP).

• Realiza lifting facial de plano profundo para elevar as bochechas e suavizar os sulcos nasolabiais.
• Utiliza lipoaspiração 360 com VASER para remoção de gordura e melhoria da qualidade da pele.
• Concluiu formação de pós-graduação em medicina estética na SACE e na SAEME, em Buenos Aires.
• Está registrado no ReTHUS e opera em instalações certificadas pela Secretaria de Saúde.

O Dr. Pastrana é um cirurgião oncológico certificado, especializado em câncer do colo do útero no Hospital Galenia.

• Certificado pelo Conacem – um órgão de acreditação reconhecido
• Membro da Sociedade Mexicana de Oncologia
• Professor universitário na Faculdade de Medicina da Universidade Anahuac desde 2020
• Concluiu a residência cirúrgica no Instituto Mexicano de Seguro Social

A Prof. Elke Jaeger foi nomeada uma das melhores oncologistas da Alemanha por 41 anos, liderando como Chefe de Oncologia na Clínica Nordwest.

• 41 anos de experiência em oncologia e hematologia
• Realizou mais de 1.100 procedimentos de tratamento de câncer
• Professora de Oncologia Interdisciplinar na Universidade de Goethe
• Especializada em pesquisa de vacinas antitumorais individualizadas
• Membro do comitê de especialistas da EORTC

Especializado em cirurgia minimamente invasiva, o Dr. Lee concentra-se no tratamento do cancro do colo do útero utilizando técnicas laparoscópicas.

• Oncoginecologista com formação especializada em cancros ginecológicos
• Especialista em procedimentos cirúrgicos laparoscópicos em oncologia
• Pratica no Gachon University Gil Medical Center

O Prof. Topcu formou-se no MD Anderson Cancer Center e especializa-se em cancros ginecológicos, incluindo o cancro do colo do útero, no Hospital Universitário Biruni.

• _doctor_9372_anos_ de experiência em oncologia médica
• Bolsa de investigação no Sunnybrook Odette Cancer Center no Canadá
• Membro da ESMO e da ASCO – sociedades oncológicas de referência
• Trabalha com protocolos de tratamento avançados para o cancro do colo do útero

A Dra. Ayşe İrem Yasin é oncologista médica no Hospital Distrital Medipol Acıbadem em Istambul. Ela possui o prestigioso certificado do conselho da ESMO. A Dra. Yasin é especializada em tumores sólidos, incluindo câncer de mama, pulmão e gastrointestinal. Ela trata casos complexos, como carcinoma de células de Merkel e cânceres de origem primária desconhecida.

• Formada na Harvard Medical School, Cleveland Clinic e no Hospital Universitário de Basileia.
• Concluiu um estágio clínico na Unidade de Câncer de Mama em Novara, Itália.
• Trata neoplasias malignas cerebrais e do SNC, sarcomas de tecidos moles e cânceres urológicos.
• Trabalha em uma instalação credenciada pela JCI equipada com o sistema robótico da Vinci.

O Prof. Associado Nail Paksoy é especializado no tratamento do cancro do colo do útero no Hospital Medipol Bahçelievler, com vasta experiência em investigação e ensaios clínicos.

• Certificado pela ESMO em Oncologia Médica
• Participou em múltiplos ensaios clínicos internacionais para tratamentos oncológicos
• Publicou numerosos artigos sobre oncologia em revistas científicas com revisão por pares

O Professor Mustafa Ondzhel é especialista em oncocirurgia e possui vasta experiência em procedimentos colorretais, incluindo casos avançados de cancro do colo do útero.

• Formado na Cleveland Clinic, nos EUA – um centro líder em proctologia e oncocirurgia
• Chefe de Cirurgia na Universidade Medipol de Istambul – supervisão de casos cirúrgicos complexos
• Vencedor de múltiplos prémios internacionais por investigações sobre o cancro colorretal
• Autor de extensas publicações sobre o adenocarcinoma retal e taxas de sobrevivência no cancro
• Membro da American Society of Colorectal Surgeons

O Dr. Atakan Topcu é oncologista médico no Hospital Medipol Acibadem District em Istambul. Especializa-se no tratamento de tumores sólidos, incluindo cancro do pulmão, da mama e colorretal. O Dr. Topcu é professor associado com mais de 50 publicações científicas revistas por pares. Faz parte do conselho editorial da revista médica BMC Cancer.

• Especialização em imunoterapia, terapias direcionadas e cuidados oncológicos geriátricos.
• Trata a desnutrição relacionada com o cancro, caquexia e sarcopenia.
• Membro ativo da Sociedade Europeia de Oncologia Médica (ESMO).
• Trabalha num hospital acreditado pela JCI, especializado em tratamentos oncológicos avançados.

O Dr. Hisham Khalifa é cirurgião oncológico consultor nos Hospitais Internacionais de Oncologia Shefaa Al Orman. Especializa-se no tratamento cirúrgico de cancros do ovário, útero e colo do útero. O Dr. Khalifa é membro do American College of Surgeons (FACS). Utiliza técnicas cirúrgicas laparoscópicas e abertas para casos de oncologia ginecológica.

• Diretor do diploma profissional de cirurgia onco-ginecológica no Instituto Nacional do Cancro.
• Membro do European Board of Surgery (UEMS).
• Membro da European Society of Surgical Oncology (ESSO).
• Ex-professor assistente de cirurgia na Universidade AlFaisal em Riade.

A Dra. Mariam Abu Zeid é oncologista clínica nos hospitais oncológicos internacionais Shefaa Al Orman. Ela é certificada pela Sociedade Europeia de Oncologia Médica (ESMO). A Dra. Abu Zeid trata tumores sólidos e cânceres hematológicos. Ela possui doutorado (Ph.D.) em Oncologia Clínica e Medicina Nuclear pela Universidade Ain Shams.

• Administra quimioterapia, imunoterapia e tratamentos direcionados para vários tipos de câncer.
• Supervisiona ensaios clínicos oncológicos e gerencia toxicidades relacionadas ao tratamento.
• Coordena o atendimento ao paciente dentro de equipes multidisciplinares para estadiamento e diagnóstico complexos.
• Atua em um centro credenciado pela ESMO que trata aproximadamente 6.000 pacientes anualmente.